South African Regulators Issue Severe Warning on Recalled Diabetes and Weight-Loss Drugs

Health authorities in South Africa have issued a critical Class I warning against the continued use, prescription, or dispensing of recalled iDEXIS Semaglutide and Tirzepatide products. These drugs were recalled in June 2026 due to significant public health dangers, representing the most serious recall category. Healthcare professionals failing to comply with the warning face disciplinary action.